Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors

European Journal of Pharmacology

Volumn 344, Issue 2-3, 1998, Pages 313-321

  Papapetropoulos, Andreas ^a   Marczin, Nandor ^a   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

CGMP; Nitric oxide (NO); Sodium nitroprusside; Tolerance

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; ENDOTOXIN; INTERLEUKIN 1BETA; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ANIMAL CELL; AORTA MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CATTLE; CONTROLLED STUDY; DRUG CROSS TOLERANCE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; CATTLE; CELLS, CULTURED; CYCLIC GMP; DRUG TOLERANCE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; PENICILLAMINE; RABBITS; RATS; SWINE;

EID: 0032485511     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01595-1     Document Type: Article

References (47)

1. Anderson, T.J., Meredith, I.T., Ganz, P., Selwyn, A.P., Yeung, A.C., 1994. Nitric oxide and nitric oxide donors: Similarities, differences and potential interactions. Am. J. Coll. Cardiol. 24, 555.
2. Bauer, J.A., Fung, H.-L., 1991. Differential hemodynamic effects and tolerance properties of nitroglycerin and S-nitrosothiol in experimental heart failure. J. Pharmacol. Exp. Ther. 256, 249-254.
3. Berkenboom, G., Fang, Z.Y., Unger, P., Fontaine, J., 1990. Effects of in vivo SIN-1 on nitrovasodilator relaxation and on EDRF-mediated responses in rat aorta. J. Cardiovasc. Pharmacol. 16, 636-640.
4. Bradford, M., 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-253.
5. Braughler, J.M., 1983. Soluble guanylate cyclase activation by nitric oxide and its reversal. Biochem. Pharmacol. 32, 811-818.
6. Bredt, D.S., Hwang, P.M., Glatt, C.E., Lowenstein, C., Reed, R.R., Snyder, S.H., 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714-718.
7. Bucala, R., Tracey, K.J., Cerami, A., 1991. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J. Clin. Invest. 87, 432-438.
8. Bult, H., DeMeyer, G.R.Y., Jordaens, F.H., Herman, A.G., 1991. Chronic exposure to exogenous nitric oxide may suppress its endogenous release and efficacy. J. Cardiovasc. Pharmacol. 17 (S3), S79-82.
9. Feelisch, M., 1991. The biochemical pathways of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17 (Suppl. 3), S225-S33.
10. Forstermann, U., Kleinhert, H., Gath, I., Schwarz, P., Closs, E.I., Dun, N.J., 1995. Expression and expressional control of nitric oxide synthases in various cell types. Adv. Pharmacol. 34, 171-186.
11. Harrison, D.G., Bates, J.N., 1993. The nitric oxide donors. New ideas about old drugs. Circulation 87, 1461-1467.
12. Harrison, D.G., Minor, R.L., Guerra, R., Quillen, J.E., Sellke, F.W., 1991. Endothelial dysfunction in atherosclerosis. In: Rubanyi, G.M. (Ed.), Cardiovascular Significance of Endothelium-derived Vasoactive Factors. Futura, New York, pp. 263-286.
13. Henry, P.J., Horowitz, J.D., Louis, W.J., 1989a. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. J. Pharmacol. Exp. Ther. 248, 762-768.
14. Henry, P.J., Drummer, O.H., Horowitz, J.D., 1989b. S-nitrosothiols as vasodilators: Implications regarding tolerance to nitric oxide-containing vasodilators. Br. J. Pharmacol. 98, 757-766.
15. Ignarro, L.J., Kadowitz, P.J., 1985. Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann. Rev. Pharmacol. 25, 171-191.
16. Katsuki, S., Arnold, W., Mittal, C., Murad, F., 1977. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3, 23-25.
17. Kojda, G., Beck, J.K., Meyer, W., Noack, E., 1994. Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: Dependence on intact endothelium. Br. J. Pharmacol. 112, 533-540.
18. Konishi, M., Su, C., 1983. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5, 881-886.
19. Kontos, H.A., Wei, E.P., Dietrich, W.D., Navari, R.M., Povlishock, J.T., Ghatak, N.R., Ellis, E.F., Patterson, J.L. Jr., 1981. Mechanism of cerebral arteriolar abnormalities after acute hypertension. Am. J. Physiol. 240, H511-H527.
20. Kowaluk, E.A., Poliszczuk, R., Fung, H.-L., 1987. Tolerance to relaxation in rat aorta: Comparison of an S-nitrosothiol with nitroglycerin. Eur. J. Pharmacol. 144, 379-383.
21. Kuchan, M.J., Frangos, J.A., 1994. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am. J. Physiol. 266, C628-C636.
22. Luscher, T.F., Vanhoutte, P.M., Boulanger, C., Dohi, Y., Buhler, F.R., 1991. Endothelial dysfunction in hypertension. In: Rubanyi, G.M. (Ed.), Cardiovascular Significance of Endothelium-derived Vasoactive Factors. Futura, New York, pp. 199-221.
23. Marczin, N., Jilling, T., Papapetropoulos, A., Go, C., Catravas, J.D., 1996. Cytoskeleton-dependent activation of the nitric oxide synthase in cultured smooth muscle cells. Br. J. Pharmacol. 118, 1085-1094.
24. Moncada, S., Palmer, R.M.J., Higgs, E.A., 1991a. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142.
25. Moncada, S., Rees, D.D., Schulz, R., Palmer, R.M.J., 1991b. Development and mechanism of a specific supersensitivity to nitric oxide donors after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA 88, 2166-2170.
26. Mülsch, A., Busse, R., Winter, I., Bassenge, E., 1989. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance. Arch. Pharmacol. 339, 568-574.
27. Münzel, T., Sayegh, H., Freeman, B.A., Tarpey, M.M., Harrison, D.G., 1995. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism for tolerance and cross tolerance. J. Clin. Invest. 95, 187-194.
28. Murohara, T., Kugiyama, K., Yasue, H., 1996. Interactions of nitrovasodilators, atrial natriuretic peptide and endothelium-derived nitric oxide. J. Vasc. Res. 33, 78-85.
29. Needleman, P., Johnson, E.M., 1973. Mechanism of tolerance development to organic nitrates. J. Pharmacol. Exp. Ther. 184, 709-715.
30. Palmer, R.M.J., Ashton, D.S., Moncada, S., 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333, 664-666.
31. Papapetropoulos, A., Marczin, N., Snead, C., Cheng, C., Milici, A., Catravas, J.D., 1994. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 23, 476-484.
32. Papapetropoulos, A., Marczin, N., Mora, G., Milici, A., Murad, F., Catravas, J.D., 1995. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension 26, 696-704.
33. Papapetropoulos, A., Cziraki, A., Rubin, J.W., Stone, C.D., Catravas, J.D., 1996a. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue. J. Cell. Physiol. 167, 213-221.
34. Papapetropoulos, A., Abou-Mohamed, G., Marczin, N., Murad, F., Caldwell, R.W., Catravas, J.D., 1996b. Downregulation of nitrovasodilator-induced cGMP accumulation in cells exposed to endotoxin or interleukin-1β. Br. J. Pharmacol. 118, 1359-1366.
35. Papapetropoulos, A., Go, C.Y., Murad, F., Catravas, J.D., 1996c. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br. J. Pharmacol. 117, 147-155.
36. Pieper, G.M., Gross, G.J., 1991. Endothelial dysfunction in diabetes. In: Rubanyi, G.M. (Ed.), Cardiovascular Significance of Endothelium-derived Vasoactive Factors. Futura, New York, pp. 223-249.
37. Ryan, U.S., Maxwell, G., 1986. Isolation, culture and subculture of bovine pulmonary artery cells: Mechanical methods. J. Tissue Culture Methods 10, 3-5.
38. Schmidt, H.H.H.W., Lohmann, S.M., Walter, U., 1993. The nitric oxide and cGMP signal transduction system: Regulation and mechanisms of action. Biochem. Biophys. Acta 1178, 153-175.
39. Sessa, W.C., Harrison, J.K., Barber, C.M., Zeng, D., Durieux, M.E., D'Angelo, D.D., Lynch, K.R., Peach, M.J., 1992. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267, 15274-15276.
40. Shaffer, J.E., Han, B.-J., Chern, W.H., Lee, F.R., 1992. Lack of tolerance to a 24 h infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits. J. Pharmacol. Exp. Ther. 261, 286-293.
41. Shirasaki, Y., Su, C., 1985. Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur. J. Pharmacol. 114, 93-96.
42. Tsuchida, S., Hiraoka, M., Sudo, M., Kigoshi, S., Muramatsu, I., 1994. Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am. J. Physiol. 267, H2305-H2310.
43. Ujiie, K., Hogarth, L., Danziger, R., Drewett, J.G., Yuen, P.S.T., Pang, I.H., Star, R.A., 1994. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells. J. Pharmacol. Exp. Ther. 270, 761-767.
44. Waldman, S.A., Murad, F., 1987. cGMP synthesis and function. Pharmacol. Rev. 39, 163-196.
45. Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T., Nathan, C., 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228.
46. Zhang, L.M., Castresana, M.R., Stefansson, S., Newmann, W.H., 1993. Tolerance to sodium nitroprusside. Studies in cultured porcine vascular smooth muscle cells. Anesthesiology 79, 1094-1103.
47. Zhang, L.M., Castresana, M.R., Newman, W.H., 1994. Tolerance to nitroglycerin in vascular smooth muscle cells: Recovery and cross-tolerance to sodium nitroprusside. Anesth. Analg. 78, 1053-1059.